Cargando…
Expectant Management of Miscarriage in View of NICE Guideline 154
Objective. To find out the success rate of conservative management of complete two weeks for miscarriage in view of NICE Guideline 154. Design. Prospective observational study. Setting. Early pregnancy assessment units of District General Hospital in the United Kingdom. Participants. Women of less t...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020214/ https://www.ncbi.nlm.nih.gov/pubmed/24868466 http://dx.doi.org/10.1155/2014/824527 |
_version_ | 1782316030241013760 |
---|---|
author | Rafi, Junaid Khalil, Haroona |
author_facet | Rafi, Junaid Khalil, Haroona |
author_sort | Rafi, Junaid |
collection | PubMed |
description | Objective. To find out the success rate of conservative management of complete two weeks for miscarriage in view of NICE Guideline 154. Design. Prospective observational study. Setting. Early pregnancy assessment units of District General Hospital in the United Kingdom. Participants. Women of less than 14 weeks' gestation, with a diagnosis of miscarriage (missed miscarriage/anembryonic or incomplete miscarriage). Interventions. Expectant management for two weeks. Main Outcome Measure. (1) Efficacy of 2-week expectant management, that is, complete resolution of miscarriage based either on self-reporting of patient after passing products of conception at home between D0 and D14 of expectant management or confirmation on scan at D14, and (2) short-term complications needing strong analgesia, blood transfusion, and antibiotics. Results. Expectant management of miscarriage for 2 weeks from the day of diagnosis was successful in 58% (64 /111) and failed in 42% (47/111). Conclusions. Expectant management success rate is consistent with the results from the longitudinal studies and RCTs published in the past. It is a safe option as none of the patients on expectant/medical management needed strong analgesia/antibiotics or blood transfusion. |
format | Online Article Text |
id | pubmed-4020214 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-40202142014-05-27 Expectant Management of Miscarriage in View of NICE Guideline 154 Rafi, Junaid Khalil, Haroona J Pregnancy Research Article Objective. To find out the success rate of conservative management of complete two weeks for miscarriage in view of NICE Guideline 154. Design. Prospective observational study. Setting. Early pregnancy assessment units of District General Hospital in the United Kingdom. Participants. Women of less than 14 weeks' gestation, with a diagnosis of miscarriage (missed miscarriage/anembryonic or incomplete miscarriage). Interventions. Expectant management for two weeks. Main Outcome Measure. (1) Efficacy of 2-week expectant management, that is, complete resolution of miscarriage based either on self-reporting of patient after passing products of conception at home between D0 and D14 of expectant management or confirmation on scan at D14, and (2) short-term complications needing strong analgesia, blood transfusion, and antibiotics. Results. Expectant management of miscarriage for 2 weeks from the day of diagnosis was successful in 58% (64 /111) and failed in 42% (47/111). Conclusions. Expectant management success rate is consistent with the results from the longitudinal studies and RCTs published in the past. It is a safe option as none of the patients on expectant/medical management needed strong analgesia/antibiotics or blood transfusion. Hindawi Publishing Corporation 2014 2014-04-27 /pmc/articles/PMC4020214/ /pubmed/24868466 http://dx.doi.org/10.1155/2014/824527 Text en Copyright © 2014 J. Rafi and H. Khalil. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Rafi, Junaid Khalil, Haroona Expectant Management of Miscarriage in View of NICE Guideline 154 |
title | Expectant Management of Miscarriage in View of NICE Guideline 154 |
title_full | Expectant Management of Miscarriage in View of NICE Guideline 154 |
title_fullStr | Expectant Management of Miscarriage in View of NICE Guideline 154 |
title_full_unstemmed | Expectant Management of Miscarriage in View of NICE Guideline 154 |
title_short | Expectant Management of Miscarriage in View of NICE Guideline 154 |
title_sort | expectant management of miscarriage in view of nice guideline 154 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020214/ https://www.ncbi.nlm.nih.gov/pubmed/24868466 http://dx.doi.org/10.1155/2014/824527 |
work_keys_str_mv | AT rafijunaid expectantmanagementofmiscarriageinviewofniceguideline154 AT khalilharoona expectantmanagementofmiscarriageinviewofniceguideline154 |